It’s no longer a secret: Ohio is an excellent place to plant a stake in the ground and launch a technology or life science startup. Smart founders are building innovative companies in all corners of the state, catalyzed by Ohio Third Frontier and a network of investors, accelerators and incubators.
With this in mind, we’re thrilled to report three entrepreneurs and companies from our portfolio have been recognized with awards from VentureOhio. Genetesis, a medical device company that’s addressing a problem that leads to eight million emergency room visits in US hospitals every year, was named 2018 Early Stage Company of the Year. The distinction comes a year after Genetesis won VentureOhio’s 2017 Seed Stage Company of the Year, and months after the company closed a $7.5M Series A financing. CincyTech led the round with participation from renowned investor Mark Cuban’s Radical Investments, as well as Ohio Innovation Fund and Raptor Group.
Co-founder and CEO Peeyush Shrivastava and team are developing a tool for emergency medicine clinicians that uses biomagnetic imaging and proprietary software to enable rapid, noninvasive and accurate triage of undiagnosed chest pain. The current standard of care is often inconclusive, forcing many patients to endure lengthy, expensive and invasive testing in the emergency and observation units of the hospital.
Finally, congratulations to the team at Hillman, a diversity and inclusion accelerator that launched in Cincinnati in 2017. CincyTech and our ecosystem partners at Cintrifuse, Brandery and UC earmarked dollars to get the Hillman team off and running, and run they have, with their vital mission. It is rewarding to see Hillman recognized by VentureOhio as a 2018 Catalyst of the Year.
(Photos of Genetesis, Key and Triplett ©2018 Stephen Takacs)